purchase customization

Leave This Empty:

choose chapter to purchase

table of content

Table of Contents

Chapter 1 Oncology Drugs Market Overview
1.1 Oncology Drugs Definition
1.2 Global Oncology Drugs Market Size Status and Outlook (2018-2032)
1.3 Global Oncology Drugs Market Size Comparison by Region (2018-2032)
1.4 Global Oncology Drugs Market Size Comparison by Type (2018-2032)
1.5 Global Oncology Drugs Market Size Comparison by Application (2018-2032)
1.6 Global Oncology Drugs Market Size Comparison by Sales Channel (2018-2032)
1.7 Oncology Drugs Market Dynamics
1.7.1 Market Drivers/Opportunities
1.7.2 Market Challenges/Risks
1.7.3 Market News (Merger/Acquisition/Expansion)
1.7.4 Key Trends in Oncology Drugs Market
Chapter 2 Oncology Drugs Market Competition by Player
2.1 Global Oncology Drugs Sales and Market Share by Player (2021-2023)
2.2 Global Oncology Drugs Revenue and Market Share by Player (2021-2023)
2.3 Global Oncology Drugs Average Price by Player (2021-2023)
2.4 Players Competition Situation & Trends
2.5 Conclusion of Segment by Player
Chapter 3 Oncology Drugs Market Segment by Type
3.1 Global Oncology Drugs Market by Type
3.1.1 Cytotoxic Drugs
3.1.2 Targeted Drugs
3.1.3 Hormonal Drugs
3.1.4 Others
3.2 Global Oncology Drugs Sales and Market Share by Type (2018-2023)
3.3 Global Oncology Drugs Revenue and Market Share by Type (2018-2023)
3.4 Global Oncology Drugs Average Price by Type (2018-2023)
3.5 Conclusion of Segment by Type
Chapter 4 Oncology Drugs Market Segment by Application
4.1 Global Oncology Drugs Market by Application
4.1.1 Lung Cancer
4.1.2 Stomach Cancer
4.1.3 Colorectal Cancer
4.1.4 Breast Cancer
4.1.5 Prostate Cancer
4.2 Global Oncology Drugs Revenue and Market Share by Application (2018-2023)
4.3 Conclusion of Segment by Application
Chapter 5 Oncology Drugs Market Segment by Sales Channel
5.1 Global Oncology Drugs Market by Sales Channel
5.1.1 Direct Channel
5.1.2 Distribution Channel
5.2 Global Oncology Drugs Revenue and Market Share by Sales Channel (2018-2023)
5.3 Conclusion of Segment by Sales Channel
Chapter 6 Oncology Drugs Market Segment by Region & Country
6.1 Global Oncology Drugs Market Size and CAGR by Region (2018-2032)
6.2 Global Oncology Drugs Sales and Market Share by Region (2018-2023)
6.3 Global Oncology Drugs Revenue and Market Share by Region (2018-2023)
6.4 North America
6.4.1 North America Market by Country
6.4.2 North America Oncology Drugs Market Share by Type
6.4.3 North America Oncology Drugs Market Share by Application
6.4.4 United States
6.4.5 Canada
6.5 Europe
6.5.1 Europe Market by Country
6.5.2 Europe Oncology Drugs Market Share by Type
6.5.3 Europe Oncology Drugs Market Share by Application
6.5.4 Germany
6.5.5 UK
6.5.6 France
6.5.7 Italy
6.5.8 Spain
6.5.9 Russia
6.6 Asia-Pacific
6.6.1 Asia-Pacific Market by Country
6.6.2 Asia-Pacific Oncology Drugs Market Share by Type
6.6.3 Asia-Pacific Oncology Drugs Market Share by Application
6.6.4 China
6.6.5 Japan
6.6.6 Korea
6.6.7 India
6.6.8 Southeast Asia
6.6.9 Australia
6.7 South America
6.7.1 South America Market by Country
6.7.2 South America Oncology Drugs Market Share by Type
6.7.3 South America Oncology Drugs Market Share by Application
6.7.4 Brazil
6.7.5 Mexico
6.7.6 Argentina
6.7.7 Colombia
6.8 Middle East & Africa
6.8.1 Middle East & Africa Market by Country
6.8.2 Middle East & Africa Oncology Drugs Market Share by Type
6.8.3 Middle East & Africa Oncology Drugs Market Share by Application
6.8.4 Turkey
6.8.5 UAE
6.8.6 Saudi Arabia
6.8.7 South Africa
6.9 Conclusion of Segment by Region
Chapter 7 Profile of Leading Oncology Drugs Players
7.1 Roche
7.1.1 Company Snapshot
7.1.2 Product/Service Offered
7.1.3 Business Performance (Sales, Price, Revenue, Gross Margin and Market Share)
7.2 Abbvie
7.3 Novartis
7.4 Pfizer
7.5 Bristol-Myers Squibb
7.6 Eli Lilly and Company
7.7 AstraZeneca
7.8 Sanofi
7.9 Bayer
7.10 Merck
7.11 Amgen
7.12 GlaxoSmithKline
7.13 BioMerieux
7.14 Bio-Rad Laboratories
7.15 Gilead Sciences
Chapter 8 Upstream and Downstream Analysis of Oncology Drugs
8.1 Industrial Chain of Oncology Drugs
8.2 Upstream of Oncology Drugs
8.3 Downstream of Oncology Drugs
Chapter 9 Development Trend of Oncology Drugs (2024-2032)
9.1 Global Oncology Drugs Market Size (Sales and Revenue) Forecast (2024-2032)
9.2 Global Oncology Drugs Market Size and CAGR Forecast by Region (2024-2032)
9.3 Global Oncology Drugs Market Size and CAGR Forecast by Type (2024-2032)
9.4 Global Oncology Drugs Market Size and CAGR Forecast by Application (2024-2032)
9.5 Global Oncology Drugs Market Size and CAGR Forecast by Sales Channel (2024-2032)
Chapter 10 Appendix
10.1 Research Methodology
10.2 Data Sources
10.3 Disclaimer
10.4 Analysts Certification